Matches in Nanopublications for { ?s ?p "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1327088.RAMLThWm0Mgk0NhO8VoRft6GMHfWP5VNwaNFPXDhubs0k130_assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327088.RAMLThWm0Mgk0NhO8VoRft6GMHfWP5VNwaNFPXDhubs0k130_provenance.
- NP1327090.RAx89WYq3-bcg8pqLinKm7ODJhmd11--hCcwA9s8GBMck130_assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327090.RAx89WYq3-bcg8pqLinKm7ODJhmd11--hCcwA9s8GBMck130_provenance.
- NP1327091.RAyDipswj4Qy_EGviMh1QhJmP95kP_Jd5vsdG1yBNnlN8130_assertion description "[Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327091.RAyDipswj4Qy_EGviMh1QhJmP95kP_Jd5vsdG1yBNnlN8130_provenance.